Brief: Passage Bio Inc - Cash On Hand To Fund Operations To Year-End 2023

Passage Bio

10/01/2022 12:20

Jan 10 (Reuters) - Passage Bio Inc  PASG.O :
    * PASSAGE BIO INC - CASH ON HAND TO FUND OPERATIONS TO YEAR-END 2023
    * PASSAGE BIO INC - SUBMIT INVESTIGATIONAL NEW DRUG APPLICATION FOR PHASE
1/2
CLINICAL PROGRAM FOR METACHROMATIC LEUKODYSTROPHY IN MID-2022
    * PASSAGE BIO INC - DOSE FIRST PATIENTS IN GLOBAL PHASE 1/2 TRIALS FOR
FRONTOTEMPORAL DEMENTIA AND KRABBE DISEASE IN EARLY 2022
    * PASSAGE BIO INC - DOSE FIRST PATIENTS IN COHORTS 2 AND 3 IN GM1
GANGLIOSIDOSIS
CLINICAL TRIAL IN EARLY 2022

Source text for Eikon:  ID:nGNX6h7Zcb 
Further company coverage:  PASG.O